The Swiss biopharmaceutical company’s shares jumped in after-hours trading after it said the FDA approved its Optune Pax product. https://t.co/uLF6Q3PtHM ...

Personnel Change - Isomorphic Labs welcomes Dr Ben Wolf as the new Chief Medical Officer [1] - Dr Wolf brings nearly 20 years of biopharmaceutical experience [1] Strategic Direction - Isomorphic Labs advances therapeutic programs into the clinic using machine learning to transform drug design [1] - Isomorphic Labs establishes a new location in Cambridge, Massachusetts [1]